
Category: Research
- ALK Experts
- ALK International
- ALK Positive News
- Clinical Trials
- Government
- Living with ALK+
- Nutrition
- Patient & Care Partner Stories
- Powered By Patients
- Recipes
- Research
-
Dr. Jessica Lin and Dr. Ibiayi Dagogo-Jack join ALKtALK
Dr. Jessica Lin Attending physician, Hematology/Oncology, Massachusetts General Hospital Instructor, Medicine, Harvard Medical School Dr. Lin: I first began interested in oncology in my undergraduate years. I started out as
-
Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations
An updated review of the most current targeted therapies in NSCLC (non-small cell lung cancer) by targetable mutation. Dr. David Konig, Dr. Spasenija S. Prince, and Dr. Sacha I Rothschild
-
Dr. Christine Lovly joins ALKtALK
Editor’s Note: A special thanks to Marc Rosenzweig for creating and scheduling the ALKtALK programs. Alice Chou graciously committed her time to transcribe thisALKtALK with Dr. Lovly so that it
-
Covid-19 vaccines and lung cancer patients
What are Covid-19 vaccines made of and how do they work? Moreover, should lung cancer patients take them? With the rise of Covid-19 infection rates and the promise of a
-
Side effects compliation & comparison
IMPORTANT: This table is a list of various side effects members have shared. Please remember, this is NOT a medical document. Please use it as a guide and a starting point.
